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Abstract
Background In 2002, the US Preventive Services Task Force recommended routine
osteoporosis screening for women aged 65 years or older. However, studies have indicated
that osteoporosis remains underdiagnosed, and various methods such as the use of health
information technology have been tried to increase screening rates. We investigated
whether we could boost the low rates of bone mineral density testing with implementation
of a point-of-care clinical decision support system in our primary care practice.
Methods We retrospectively reviewed the medical records of female patients eligible for
osteoporosis screening who had no prior bone mineral density test who were seen at our
primary care practice sites in 2007 or 2008 (before and after implementation of a point-
of-care clinical decision support system).
Results Overall, screening rates were 80.1% in 2007 and 84.1% in 2008 (P < 0.001). Of
patients who did not have osteoporosis screening before the visit, 5.87% completed the
screening after the visit in 2007, compared with 9.79% in 2008 (when the clinical support
system was implemented), a 66.7% improvement (P = 0.025).
Conclusion Clinical decision support for primary care doctors signiﬁcantly improved
osteoporosis screening rates among eligible women. Carefully designed clinical decision
support systems can optimize care delivery, ensuring that important preventive services
such as osteoporosis screening for patients at risk for fracture are performed while unnec-
essary testing is avoided.
Introduction
Despite national osteoporosis screening guidelines recommend-
ing routine screening for women aged 65 years or older [1–3],
studies have identiﬁed rates of screening in primary care settings
as low as 12% [4]. Studies of the efﬁcacy of different inter-
ventions to screen more eligible women has led to mounting
evidence that health information technology (HIT) improves
adherence to osteoporosis screening guidelines [5]. However,
doctors have been reluctant adopters of HIT because of the
expense and time required to change their ofﬁce systems or
because they are not convinced of the beneﬁts of doing so [6]. As
a result, the health care industry lags behind other sectors in IT
investment [7]. This means that applications that may narrow
gaps in care (e.g. clinical decision support systems that prompt
doctors to discuss preventive services with patients) are not being
fully deployed.
Osteoporosis, a common condition that affects about eight
million women and two million men in the USA, is characterized
by low bone mass and structural deterioration of bone tissue,
leading to increased bone fragility. It poses an increased risk of
fracture for people older than 50 years and, if left untreated, its
debilitating consequences constitute a substantial national eco-
nomic burden [1,8]. Experts predict that total medical costs from
fractures will rise by almost 50%, to $25.3 billion, in 2025 (from
$19 billion in 2005) [1,9]. To address this growing threat, the 2002
US Preventive Services Task Force, the National Osteoporosis
Foundation and, most recently, the American College of Preven-
tive Medicine, recommended routine screening for osteoporosis
for all women aged 65 years or older [1–3]. Screening should
begin earlier in postmenopausal women with risk factors for
osteoporosis [1,3]. To date, mineral bone density measured by
dual-energy X-ray absorptiometry (DEXA) is the best predictor
for fracture [1,2,10].
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screening rate remains low. One 2002 study found that only
12–34% of women at high risk for fracture in a managed care
network were screened for osteoporosis [4]. Another study
reported that just 45% of 6311 at-risk patients seen by 160 doctors
in 10 primary care sites had a prior bone mineral density test [11].
The mean rate of screening in one primary care group practice was
56% [12]. Less than 50% of 1200 adults aged 60 years or older
surveyed in the north-eastern USA said that their doctor recom-
mended osteoporosis screening [13].
Time constraints are a major limiting factor in primary care
doctors’ ability to deliver preventive services [14]. Clinical deci-
sion support technology increases efﬁciency and the likelihood
that patients will get the care they need. Such information systems
help identify and screen patients who are due for preventive ser-
vices, independent of direct doctor contact. A review of random-
ized controlled trials of the use of computerized prompts for the
provider at the point of care found an increased rate of bone
mineral density testing [15].
In a prior study at Mayo Clinic Rochester, a population-based
information system improved the rate of mammography screening
[16].Asubsequent study from the same institution showed signiﬁ-
cant improvement in osteoporosis screening with the use of a
medical record-based information system. In that study, women
eligible for osteoporosis screening were identiﬁed and classiﬁed
into either an intervention group that was sent letters requesting
themtomakeanappointmentforaDEXAscanortoacontrolgroup
[17].Although limited by the small number of patients who under-
went initial osteoporosis screening, the study still showed very
encouraging results, as 25% of the intervention group completed
screening in response to one letter inviting them to the screening.
Another recently completed study using a clinical decision support
system showed improved delivery ofAbdominalAorticAneurysm
screening (R. Chaudhry et al., unpublished observation). In this
study, we looked at improving the osteoporosis screening rate
of eligible female patients seen at the Primary Care Internal Medi-
cine and Family Medicine clinics through implementation of a
point-of-care clinical decision support system in January 2008.
Methods
Mayo Clinic’s Employee and Community Health practice pro-
vides primary care to 140 000 patients in Primary Care Internal
Medicine, Family Medicine and Community Pediatrics. The
Employee and Community Health practice sites in the Rochester
area are staffed by 45 internists and 40 family doctors.
The Generic Disease Management Systems (GDMS) software
is a Web-based application developed by VitalHealth, a joint
venture between Mayo Clinic and Netherlands-based Noaber
Foundation. Details of its features were reported in a previous
study (R. Chaudhry et al., unpublished observation). The GDMS
includes a rules-based application coded with national guidelines
for age- and sex-speciﬁc preventive services and process and
outcome measures for diabetes and coronary artery disease. On the
basis of the data fromWeb services, the rules provide point-of-care
decision support regarding the services that the patient needs at the
time of their visit and in the next 90 days. It also automatically
checks for a prior bone density test.
The GDMS was developed and successfully pilot tested in
December 2007, and the system was made available to all practice
sites of the Employee and Community Health practice for adults in
January 2008. With the new workﬂow, when a patient visits a site
for any reason (e.g. acute condition, chronic disease, annual
examination), a paper copy of the GDMS summary screen is
printed by check-in staff and is included in the rooming packet for
the allied health staff. Women who meet initial osteoporosis
screening criteria (65 years or older) can then have the order
placed (per protocol) for DEXA by the rooming personnel. The
order is then activated by the provider after discussion with the
patient.
An independent data abstractor reviewed all the records of
female patients aged 65 years or older who were seen in three
Employee and Community Health practice sites in 2007 and 2008
and who had no prior bone density test. The completion rate of
initial osteoporosis screening from January to December 2007 was
compared with the rate from January to December 2008 (1 year
after the GDMS implementation). A subanalysis of osteoporosis
screening completion within 30 days from the clinic visit was done
for the ﬁrst 4 months of 2007 and 2008. This was undertaken to
evaluate the efﬁciency of the new workﬂow and the point-of-care
clinical decision support tool in facilitating screening completion.
Chi-squared test was used to determine differences in outcome
and a two-tailed P-value of <0.05 was considered statistically
signiﬁcant.
Results
In 2007, 7263 women were eligible for osteoporosis screening. Of
these women, 5817 (80.1%) completed an initial screening test by
the end of the year. After implementation of the point-of-care
clinical decision support tool in 2008, 6234 (84.1%) of the 7411
eligible women completed osteoporosis screening by the end of
the year (see Table 1; c2 = 40.254; P < 0.001).
Subanalysis of data abstracted on osteoporosis screening among
Family Medicine practice sites during the ﬁrst 4 months of the
GDMS implementation in 2008 was done (see Table 2); the result-
ing data were compared with data from the ﬁrst 4 months in 2007.
Of the 2212 eligible women seen at those sites from January to
Table 1 Women obtaining osteoporosis screening before and after clinical decision support tool implementation
2007 (before clinical decision
support tool implementation)
2008 (after clinical decision
support tool implementation)
Number of women eligible for screening 7263 7411
Number of women screened 5817 6234
Percentage of eligible women screened 80.1% 84.1%
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(5.87%) screenings were completed after a clinic visit that year.
During the ﬁrst 4 months of GDMS implementation in 2008, 490
of the 2418 eligible women seen in were identiﬁed by the GDMS
as requiring baseline osteoporosis screening. Of these women, 48
(9.79%) completed screening within 30 days after the visit
(P = 0.025).
Discussion
In our study, the overall osteoporosis screening rate among all
eligible female patients grew roughly 4% 1 year after initiation of
a point-of-care clinical decision support tool (i.e. the GDMS) in
primary care. The tool’s utilization in face-to-face encounters led
to increased completion of screening after a clinic visit by identi-
fying eligible patients and alerting their providers, who then
engaged patients in the discussion. This was clearly shown by the
66.7% improvement for the eligible patients compared with the
same time period in 2007, when we did not have the decision
support tool (P = 0.025). However, not all patients who were iden-
tiﬁed by the decision support to be eligible for screening received
it, which highlights the importance of having processes in place to
support the decision support for the services that are due. Primary
care doctors have many tasks to perform during a 15- to 20-minute
visit; having allied health staff take on the responsibility for
helping the doctors deliver the necessary services can lead to better
results [18].
Improvement of health care value relies on payment reform that
pays for value rather than volume of services. Decision support
tools that help improve quality are essential. Without these tools,
health care providers would need to determine the need for screen-
ing through a manual process, which is time-consuming and unre-
liable. Also, identifying women in need of treatment through
screening can markedly reduce fractures, improve quality life and
contain overall health care costs on an individual and national
basis [19,20].
Our study has several strengths, including its large sample size
and completeness in identifying women for screening with the
GDMS. We showed signiﬁcant improvement in osteoporosis
screening completion among a study population of community-
dwelling women seen in a primary care practice, an area that is
most affected by performance measures on preventive health
screening and chronic disease management. The use of point-of-
care clinical decision support tools like the GDMS can help
increase primary care providers’ efﬁciency of time allocation,
enable them to engage patients in their care and lead to improved
outcomes and higher career satisfaction by decompressing taxed
practices [5,21]. Our results cannot be generalized to all minority
groups, because most of the women in our study are White.
However, osteoporosis is most prevalent in White and Asian
women [1].
In conclusion, we observed an improved baseline osteoporosis
screening rate among eligible female patients in our primary care
practice using the GDMS point-of-care clinical decision support
tool. Early identiﬁcation of at-risk patients allows the institution of
non-pharmacologic and pharmacologic measures that can help
prevent devastating and potentially life-threatening fractures. This
is an important step towards achieving better health outcomes and
may serve as a model for future public health initiatives.
We may be able to expand the reach of our osteoporosis screen-
ing programme even more by developing a deeper understanding
of workﬂow, information ﬂow, barriers to use and provider needs
in our primary care clinics [22]. Such knowledge could help us
optimize use of the clinical decision support tool to ensure that
patients get the care they need when they need it.
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